by Robert Hayes Posted on May 17, 2021May 17, 2021 BUSINESS BRIEF: Wilmington’s Charles River Labs To Acquire Vigene Biosciences To Enhance Gene Therapy Capabilities Read More
by Robert Hayes Posted on April 6, 2021April 6, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Completes Acquisition Of Cognate BioServices For $875 Million Read More
by Robert Hayes Posted on April 5, 2021April 5, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires Retrogenix Read More
by Robert Hayes Posted on February 21, 2021February 21, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories To Acquire Cognate BioServices For $875 Million Read More
by Robert Hayes Posted on January 16, 2021January 16, 2021 BUSINESS BRIEF: Charles River Partners With JADE Biomedical To Expand Biologics Capabilities Read More
by Robert Hayes Posted on January 5, 2021January 5, 2021 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires Distributed Bio Read More
by Robert Hayes Posted on October 16, 2020October 17, 2020 Wilmington’s Charles River Laboratories Adds George Llado To Board Of Directors Read More
by Robert Hayes Posted on April 23, 2020April 24, 2020 PETA Demands Wilmington’s Charles River Labs Suspend All Experiments On Monkeys Due To COVID-19 Read More
by Robert Hayes Posted on March 30, 2020March 31, 2020 Wilmington’s Charles River Labs & Deciphex Form Partnership To Enhance Drug Discovery & Development With Digital Pathology Read More
by Robert Hayes Posted on March 7, 2020March 7, 2020 BUSINESS BRIEF: Charles River Labs Adds Dr. Nancy Andrews To Board of Directors Read More
Wilmington Apple 
You must be logged in to post a comment.